Cargando…
Development of a Simple Assay Method for Adenosine Deaminase via Enzymatic Formation of an Inosine-Tb(3+) Complex
Adenosine deaminase (ADA), which catalyzes the irreversible deamination of adenosine to inosine, is related to various human diseases such as tuberculous peritonitis and leukemia. Therefore, the method used to detect ADA activity and screen the effectiveness of various inhibitor candidates has impor...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631010/ https://www.ncbi.nlm.nih.gov/pubmed/31216643 http://dx.doi.org/10.3390/s19122728 |
_version_ | 1783435430224461824 |
---|---|
author | Lee, Suji Park, Heewon Ki, Yeongcheol Lee, Hohjai Han, Min Su |
author_facet | Lee, Suji Park, Heewon Ki, Yeongcheol Lee, Hohjai Han, Min Su |
author_sort | Lee, Suji |
collection | PubMed |
description | Adenosine deaminase (ADA), which catalyzes the irreversible deamination of adenosine to inosine, is related to various human diseases such as tuberculous peritonitis and leukemia. Therefore, the method used to detect ADA activity and screen the effectiveness of various inhibitor candidates has important implications for the diagnosis treatment for various human diseases. A simple and rapid assay method for ADA, based on the enzymatic formation of a luminescent lanthanide complex, is proposed in this study. Inosine, an enzymatic product of ADA with stronger sensitization efficiency for Tb(3+) than adenosine, produced a strong luminescence by forming an inosine-Tb(3+) complex, and it enabled the direct monitoring of ADA activity in real-time. By introducing only Tb(3+) to adenosine and ADA in the buffer, the enhancement of luminescence enabled the detection of a low concentration of ADA (detection limit 1.6 U/L). Moreover, this method could accurately determine the inhibition efficiency (IC(50)) of the known ADA inhibitor, erhythro-9-(2-hydroxy-3-nonyl)adenine (EHNA), and the inhibition of ADA could be confirmed by the naked eye. Considering its simplicity, this assay could be extended to the high-throughput screening of various ADA inhibitor candidates. |
format | Online Article Text |
id | pubmed-6631010 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-66310102019-08-19 Development of a Simple Assay Method for Adenosine Deaminase via Enzymatic Formation of an Inosine-Tb(3+) Complex Lee, Suji Park, Heewon Ki, Yeongcheol Lee, Hohjai Han, Min Su Sensors (Basel) Article Adenosine deaminase (ADA), which catalyzes the irreversible deamination of adenosine to inosine, is related to various human diseases such as tuberculous peritonitis and leukemia. Therefore, the method used to detect ADA activity and screen the effectiveness of various inhibitor candidates has important implications for the diagnosis treatment for various human diseases. A simple and rapid assay method for ADA, based on the enzymatic formation of a luminescent lanthanide complex, is proposed in this study. Inosine, an enzymatic product of ADA with stronger sensitization efficiency for Tb(3+) than adenosine, produced a strong luminescence by forming an inosine-Tb(3+) complex, and it enabled the direct monitoring of ADA activity in real-time. By introducing only Tb(3+) to adenosine and ADA in the buffer, the enhancement of luminescence enabled the detection of a low concentration of ADA (detection limit 1.6 U/L). Moreover, this method could accurately determine the inhibition efficiency (IC(50)) of the known ADA inhibitor, erhythro-9-(2-hydroxy-3-nonyl)adenine (EHNA), and the inhibition of ADA could be confirmed by the naked eye. Considering its simplicity, this assay could be extended to the high-throughput screening of various ADA inhibitor candidates. MDPI 2019-06-18 /pmc/articles/PMC6631010/ /pubmed/31216643 http://dx.doi.org/10.3390/s19122728 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lee, Suji Park, Heewon Ki, Yeongcheol Lee, Hohjai Han, Min Su Development of a Simple Assay Method for Adenosine Deaminase via Enzymatic Formation of an Inosine-Tb(3+) Complex |
title | Development of a Simple Assay Method for Adenosine Deaminase via Enzymatic Formation of an Inosine-Tb(3+) Complex |
title_full | Development of a Simple Assay Method for Adenosine Deaminase via Enzymatic Formation of an Inosine-Tb(3+) Complex |
title_fullStr | Development of a Simple Assay Method for Adenosine Deaminase via Enzymatic Formation of an Inosine-Tb(3+) Complex |
title_full_unstemmed | Development of a Simple Assay Method for Adenosine Deaminase via Enzymatic Formation of an Inosine-Tb(3+) Complex |
title_short | Development of a Simple Assay Method for Adenosine Deaminase via Enzymatic Formation of an Inosine-Tb(3+) Complex |
title_sort | development of a simple assay method for adenosine deaminase via enzymatic formation of an inosine-tb(3+) complex |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631010/ https://www.ncbi.nlm.nih.gov/pubmed/31216643 http://dx.doi.org/10.3390/s19122728 |
work_keys_str_mv | AT leesuji developmentofasimpleassaymethodforadenosinedeaminaseviaenzymaticformationofaninosinetb3complex AT parkheewon developmentofasimpleassaymethodforadenosinedeaminaseviaenzymaticformationofaninosinetb3complex AT kiyeongcheol developmentofasimpleassaymethodforadenosinedeaminaseviaenzymaticformationofaninosinetb3complex AT leehohjai developmentofasimpleassaymethodforadenosinedeaminaseviaenzymaticformationofaninosinetb3complex AT hanminsu developmentofasimpleassaymethodforadenosinedeaminaseviaenzymaticformationofaninosinetb3complex |